PortfoliosLab logoPortfoliosLab logo
INMB vs. AIRO
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

INMB vs. AIRO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in INmune Bio, Inc. (INMB) and AIRO Group Holdings, Inc (AIRO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

INMB vs. AIRO - Yearly Performance Comparison


2026 (YTD)2025
INMB
INmune Bio, Inc.
-27.56%-79.74%
AIRO
AIRO Group Holdings, Inc
-7.03%-65.92%

Fundamentals

EPS

INMB:

-$2.00

AIRO:

-$287.02

PS Ratio

INMB:

563.69

AIRO:

0.03

Total Revenue (TTM)

INMB:

$50.00K

AIRO:

$6.36B

Gross Profit (TTM)

INMB:

$22.00K

AIRO:

$2.84B

EBITDA (TTM)

INMB:

-$33.62M

AIRO:

-$5.36B

Returns By Period

In the year-to-date period, INMB achieves a -27.56% return, which is significantly lower than AIRO's -7.03% return.


INMB

1D
-0.88%
1M
-12.40%
YTD
-27.56%
6M
-45.41%
1Y
-85.53%
3Y*
-44.07%
5Y*
-37.99%
10Y*

AIRO

1D
-11.26%
1M
-22.40%
YTD
-7.03%
6M
-60.39%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


INmune Bio, Inc.

AIRO Group Holdings, Inc

Return for Risk

INMB vs. AIRO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INMB
INMB Risk / Return Rank: 77
Overall Rank
INMB Sharpe Ratio Rank: 77
Sharpe Ratio Rank
INMB Sortino Ratio Rank: 44
Sortino Ratio Rank
INMB Omega Ratio Rank: 44
Omega Ratio Rank
INMB Calmar Ratio Rank: 33
Calmar Ratio Rank
INMB Martin Ratio Rank: 1717
Martin Ratio Rank

AIRO
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INMB vs. AIRO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for INmune Bio, Inc. (INMB) and AIRO Group Holdings, Inc (AIRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INMBAIRODifference

Sharpe ratio

Return per unit of total volatility

-0.86

Sortino ratio

Return per unit of downside risk

-1.62

Omega ratio

Gain probability vs. loss probability

0.78

Calmar ratio

Return relative to maximum drawdown

-0.98

Martin ratio

Return relative to average drawdown

-1.25

INMB vs. AIRO - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


INMBAIRODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.86

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.26

-0.76

+0.50

Correlation

The correlation between INMB and AIRO is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

INMB vs. AIRO - Dividend Comparison

Neither INMB nor AIRO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

INMB vs. AIRO - Drawdown Comparison

The maximum INMB drawdown since its inception was -95.98%, which is greater than AIRO's maximum drawdown of -76.10%. Use the drawdown chart below to compare losses from any high point for INMB and AIRO.


Loading graphics...

Drawdown Indicators


INMBAIRODifference

Max Drawdown

Largest peak-to-trough decline

-95.98%

-76.10%

-19.88%

Max Drawdown (1Y)

Largest decline over 1 year

-86.41%

Max Drawdown (5Y)

Largest decline over 5 years

-95.98%

Current Drawdown

Current decline from peak

-95.94%

-75.47%

-20.47%

Average Drawdown

Average peak-to-trough decline

-59.63%

-49.47%

-10.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.80%

Volatility

INMB vs. AIRO - Volatility Comparison


Loading graphics...

Volatility by Period


INMBAIRODifference

Volatility (1M)

Calculated over the trailing 1-month period

21.58%

Volatility (6M)

Calculated over the trailing 6-month period

48.63%

Volatility (1Y)

Calculated over the trailing 1-year period

100.11%

101.52%

-1.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.48%

101.52%

-14.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.16%

101.52%

-8.36%

Financials

INMB vs. AIRO - Financials Comparison

This section allows you to compare key financial metrics between INmune Bio, Inc. and AIRO Group Holdings, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJuly0
6.28B
(INMB) Total Revenue
(AIRO) Total Revenue
Values in USD except per share items